Pennsylvania

Home
Chapter Facts/Mission/Bylaws
Officers/Committees
Cardiac Care Associates (CCA)
Fellows-In-Training
Membership Directory
Newsletter/Classifieds
Meetings & Events
Coding Seminars
Payer Advocacy
Position Statement Responses
Legislative Update
ACC / CAN
Online Education
Contact Us
Chapter Awards
Links

Online Education

2007 Chapter Meeting Presentations

2006 Chapter Meeting Presentations

Type-2 Diabetes Mellitus - Learn more about Type-2 Diabetes Mellitus since long-term complications of diabetes include CVD. In fact, two out of three people with diabetes die from CVD.


2007 Chapter Meeting Presentations:

Presentations from the Annual Chapter Meeting held October 12-14, 2007.
All files are in a MS PowerPoint Show (.PPS) format. You do not need to have MS PowerPoint Installed on your computer to view the files. Each link opens a new window.

Transforming Science into Quality Care
by Alfred A. Bove, MD, PhD
Treat Everyone to an LDL-C or 70mg/dl?
by Daniel Edmundowicz MS, MD, FACC
Reimbursement Challenges and Solutions for Cardiovascular Specialists
by Kathleen Flood, Director, Payer Advocacy
Gloom, Doom, and the Baby Boom: HealthCare in the Future
by Raymond J. Gibbons, MD [ File 1 ] [ File 2 ]
Negotiating Your Employment Contract
by Vasilios J.Kalogredis, Esq.
Treatment of Atrial Fibrillation: 2007 Update
by David L. Scher, FACP, FACC, FHRS
Achieving Accreditation in Echo, Nuclear and Vascular
by Robert Skotnicki DO, FACC
LDL: Lower IS Better
by Andrew R. Waxler, MD, FACC
Task Force on Performance Assessment, Recognition, Reinforcement and Reward (PAR3)
by Janet Wright MD, FACC


2006 Chapter Meeting Presentations:

Presentations from the 2006 Annual Chapter Meeting, held Friday, April 28, 2006 at the Wyndham Harrisburg-Hershey in Harrisburg, PA:

CCA Practice Models
Billing for Nurse Practitioner Services
Michelle Ashby, CRNP and Paul Casale, MD, FACC

Cardiac CT and CT Angiography: Techniques and Clinical Applications
Ethan J. Halpern, MD

Innovative Surgical Techniques
Walter Pae, Jr., MD, FACC, FACS

ACC Goals & Initiatives Including Imaging
Gerald V. Naccarelli, MD, FACC

Nuclear Imaging
Bindukumar C. Kansupada, MD, FACC, MBA


Type-2 Diabetes Mellitus:

T2DM Drivers

Driver One
Reducing blood glucose and HbA1c levels reduces the risk of diabetic complications. Intensive therapy has been shown to be superior to conventional therapy in terms of reducing glycemia and diabetic complications.

Driver Two
When monotherapy with an oral agent is no longer adequate, combination therapy with two or more oral agents has been shown to significantly improve glycemic control.

Driver Three
When oral monotherapy or combination oral therapy is no longer adequate, insulin can be added to the regimen to significantly improve glycemic control.

Driver Four
Benefits of insulin therapy, such as improved outcomes and glycemic control, outweigh risks such as the potential for inducing hypoglycemia.

Driver Five
Type 2 diabetes mellitus is a disease consisting of two components: insulin resistance and insulin deficiency.

Read the full diabetes module for cardiology.

This Scientific Evidence Based Medicine Module was funded by an educational grant from Sanofi-Aventis Pharmaceuticals Education Center.